Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Nat Commun. 2022 Jan 19;13(1):383. doi: 10.1038/s41467-022-28064-7.
Nat Commun. 2022.
PMID: 35046397
Free PMC article.
Clinical Trial.
Item in Clipboard
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
Bandopadhyay P, D'Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR, Roy R, Maiti R, Chaudhuri K, Bagchi S, Maiti A, Perwez MM, Sarkar BS, Roy D, Chakraborty R, Vasudevan JS, Sharma S, Biswas D, Maiti C, Saha B, Bhattacharya P, Pandey R, Chatterjee S, Paul S, Ganguly D.
Bandopadhyay P, et al. Among authors: perwez mm.
J Infect Dis. 2021 Aug 16;224(4):565-574. doi: 10.1093/infdis/jiab010.
J Infect Dis. 2021.
PMID: 34398242
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite